Clinical trials
Trials in Sweden with no applicable phase and unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
400 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 9 |
| 2009 | 14 |
| 2010 | 11 |
| 2011 | 16 |
| 2012 | 13 |
| 2013 | 15 |
| 2014 | 21 |
| 2015 | 16 |
| 2016 | 19 |
| 2017 | 23 |
| 2018 | 33 |
| 2019 | 28 |
| 2020 | 30 |
| 2021 | 53 |
| 2022 | 39 |
| 2023 | 37 |
| 2024 | 13 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 400 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Karolinska Institutet | 51 |
| Umeå University | 32 |
| Karolinska University Hospital | 29 |
| Uppsala University | 26 |
| Linkoeping University | 14 |
| Sahlgrenska University Hospital | 14 |
| University Hospital, Linkoeping | 14 |
| Region Skane | 12 |
| Danderyd Hospital | 11 |
| Lund University | 11 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 12 |
| Atrial Fibrillation | 11 |
| Breast Neoplasms | 9 |
| Chronic Pain | 9 |
| Anxiety Disorders | 8 |
| Colorectal Neoplasms | 7 |
| Obesity | 7 |
| Cognitive Dysfunction | 6 |
| Diabetes Mellitus, Type 2 | 6 |
| Mental Disorders | 6 |
Trials
Showing 1 to 25 of 400. Each trial links to its page on Pharma Observatory.
300 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.